Home/Filings/4/A/0001214659-20-009413
4/A//SEC Filing

REED VICKIE S 4/A

Accession 0001214659-20-009413

CIK 0001576263other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 6:21 PM ET

Size

5.8 KB

Accession

0001214659-20-009413

Insider Transaction Report

Form 4/AAmended
Period: 2020-11-02
REED VICKIE S
SVP, Chief Accounting Officer
Transactions
  • Award

    Option Grant (Right to Buy)

    2020-11-02+2,5222,522 total
    Exercise: $216.11Exp: 2030-11-01CommonStock (2,522 underlying)
Footnotes (2)
  • [F1]Quantity reduced by 1 share after corrected calculation of fair value.
  • [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001405637

Filing Metadata

Form type
4/A
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:21 PM ET
Size
5.8 KB